MammoSite Targeted Radiation Therapy: Print Page

About Cytyc

Cytyc Corporation is a diversified diagnostic and medical device company that designs, develops, manufactures, and markets innovative and clinically effective diagnostic and surgical products. Cytyc's products cover a range of cancer and women's health applications, including cervical cancer screening, treatment of excessive menstrual bleeding and early-stage breast cancer.

MammoSite® 5-Day Targeted Radiation Therapy

MammoSite allows physicians to deliver radiation from inside the breast following removal of an early-stage breast cancer tumor. This technology enables women to complete radiation therapy in just 5 days.

ThinPrep® System

The ThinPrep System is the most widely used method for cervical cancer screening in the United States.  

NovaSure® System

Cytyc Surgical Products Division markets the NovaSure System, an innovative endometrial ablation device to treat menorrhagia, or excessive menstrual bleeding.   

FullTerm® The Fetal Fibronectin Test

A non-invasive test approved for use in pregnant women from 22 to 35 weeks of gestation to help manage pregnancy.